Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Nasal Polyps Diagnosis and Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Nasal Polyps Diagnosis and Treatmentmarket, defines the market attractiveness level of Nasal Polyps Diagnosis and Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Nasal Polyps Diagnosis and Treatment industry, describes the types of Nasal Polyps Diagnosis and Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Nasal Polyps Diagnosis and Treatment market and the development prospects and opportunities of Nasal Polyps Diagnosis and Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Nasal Polyps Diagnosis and Treatment market in Chapter 13.
By Player:
Intersect ENT
Merck
Novartis
F Hoffmann La-Roche
Sanofi
Pfizer
Regeneron Pharmaceuticals
OptiNose US
GlaxoSmithKline
By Type:
Pharmacological Therapies
Surgeries
By End-User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Nasal Polyps Diagnosis and Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Nasal Polyps Diagnosis and Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Nasal Polyps Diagnosis and Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Nasal Polyps Diagnosis and Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Nasal Polyps Diagnosis and Treatment Market Analysis and Outlook to 2022
-
7.1 Global Nasal Polyps Diagnosis and Treatment Consumption (2017-2022)
-
7.2 United States Nasal Polyps Diagnosis and Treatment Consumption (2017-2022)
-
7.3 Europe Nasal Polyps Diagnosis and Treatment Consumption (2017-2022)
-
7.4 China Nasal Polyps Diagnosis and Treatment Consumption (2017-2022)
-
7.5 Japan Nasal Polyps Diagnosis and Treatment Consumption (2017-2022)
-
7.6 India Nasal Polyps Diagnosis and Treatment Consumption (2017-2022)
-
7.7 South Korea Nasal Polyps Diagnosis and Treatment Consumption (2017-2022)
8 Region and Country-wise Nasal Polyps Diagnosis and Treatment Market Analysis and Outlook to 2028
-
8.1 Global Nasal Polyps Diagnosis and Treatment Consumption Forecast (2022-2028)
-
8.2 United States Nasal Polyps Diagnosis and Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Nasal Polyps Diagnosis and Treatment Consumption Forecast (2022-2028)
-
8.4 China Nasal Polyps Diagnosis and Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Nasal Polyps Diagnosis and Treatment Consumption Forecast (2022-2028)
-
8.6 India Nasal Polyps Diagnosis and Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Nasal Polyps Diagnosis and Treatment Consumption Forecast (2022-2028)
9 Global Nasal Polyps Diagnosis and Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Nasal Polyps Diagnosis and Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Pharmacological Therapies Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Surgeries Consumption and Growth Rate (2017-2022)
-
9.2 Global Nasal Polyps Diagnosis and Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Specialty Clinics Consumption and Growth Rate (2017-2022)
10 Global Nasal Polyps Diagnosis and Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Nasal Polyps Diagnosis and Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Pharmacological Therapies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Surgeries Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Nasal Polyps Diagnosis and Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)
11 Global Nasal Polyps Diagnosis and Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Nasal Polyps Diagnosis and Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Nasal Polyps Diagnosis and Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Nasal Polyps Diagnosis and Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Nasal Polyps Diagnosis and Treatment Market Competitive Analysis
-
14.1 Intersect ENT
-
14.1.1 Intersect ENT Company Details
-
14.1.2 Intersect ENT Nasal Polyps Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Intersect ENT Nasal Polyps Diagnosis and Treatment Product and Service
-
14.2 Merck
-
14.2.1 Merck Company Details
-
14.2.2 Merck Nasal Polyps Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Merck Nasal Polyps Diagnosis and Treatment Product and Service
-
14.3 Novartis
-
14.3.1 Novartis Company Details
-
14.3.2 Novartis Nasal Polyps Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis Nasal Polyps Diagnosis and Treatment Product and Service
-
14.4 F Hoffmann La-Roche
-
14.4.1 F Hoffmann La-Roche Company Details
-
14.4.2 F Hoffmann La-Roche Nasal Polyps Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 F Hoffmann La-Roche Nasal Polyps Diagnosis and Treatment Product and Service
-
14.5 Sanofi
-
14.5.1 Sanofi Company Details
-
14.5.2 Sanofi Nasal Polyps Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Sanofi Nasal Polyps Diagnosis and Treatment Product and Service
-
14.6 Pfizer
-
14.6.1 Pfizer Company Details
-
14.6.2 Pfizer Nasal Polyps Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Pfizer Nasal Polyps Diagnosis and Treatment Product and Service
-
14.7 Regeneron Pharmaceuticals
-
14.7.1 Regeneron Pharmaceuticals Company Details
-
14.7.2 Regeneron Pharmaceuticals Nasal Polyps Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Regeneron Pharmaceuticals Nasal Polyps Diagnosis and Treatment Product and Service
-
14.8 OptiNose US
-
14.8.1 OptiNose US Company Details
-
14.8.2 OptiNose US Nasal Polyps Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 OptiNose US Nasal Polyps Diagnosis and Treatment Product and Service
-
14.9 GlaxoSmithKline
-
14.9.1 GlaxoSmithKline Company Details
-
14.9.2 GlaxoSmithKline Nasal Polyps Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 GlaxoSmithKline Nasal Polyps Diagnosis and Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Nasal Polyps Diagnosis and Treatment
-
Figure Nasal Polyps Diagnosis and Treatment Picture
-
Table Global Nasal Polyps Diagnosis and Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Nasal Polyps Diagnosis and Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Nasal Polyps Diagnosis and Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Nasal Polyps Diagnosis and Treatment Consumption by Country (2017-2022)
-
Figure United States Nasal Polyps Diagnosis and Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Nasal Polyps Diagnosis and Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Nasal Polyps Diagnosis and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Nasal Polyps Diagnosis and Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Nasal Polyps Diagnosis and Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Nasal Polyps Diagnosis and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Nasal Polyps Diagnosis and Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Nasal Polyps Diagnosis and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Nasal Polyps Diagnosis and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Nasal Polyps Diagnosis and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Nasal Polyps Diagnosis and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Nasal Polyps Diagnosis and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Nasal Polyps Diagnosis and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmacological Therapies Consumption and Growth Rate (2017-2022)
-
Figure Global Surgeries Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Specialty Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmacological Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Surgeries Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Nasal Polyps Diagnosis and Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Nasal Polyps Diagnosis and Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Intersect ENT (Foundation Year, Company Profile and etc.)
-
Table Intersect ENT Nasal Polyps Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Intersect ENT Nasal Polyps Diagnosis and Treatment Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Nasal Polyps Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Nasal Polyps Diagnosis and Treatment Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Nasal Polyps Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Nasal Polyps Diagnosis and Treatment Product and Service
-
Table F Hoffmann La-Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann La-Roche Nasal Polyps Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann La-Roche Nasal Polyps Diagnosis and Treatment Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Nasal Polyps Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Nasal Polyps Diagnosis and Treatment Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Nasal Polyps Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Nasal Polyps Diagnosis and Treatment Product and Service
-
Table Regeneron Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Regeneron Pharmaceuticals Nasal Polyps Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Regeneron Pharmaceuticals Nasal Polyps Diagnosis and Treatment Product and Service
-
Table OptiNose US (Foundation Year, Company Profile and etc.)
-
Table OptiNose US Nasal Polyps Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table OptiNose US Nasal Polyps Diagnosis and Treatment Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Nasal Polyps Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Nasal Polyps Diagnosis and Treatment Product and Service
-
